CROI 2019
Investigational HIV Drug Not Associated With Weight Gain
Cabotegravir, an investigational novel integrase inhibitor, does not appear to cause weight gain.
MARCH 20, 2019
Long-Acting Shot Preferred to Oral Therapy in 2 HIV Studies
The investigational long-acting injectable treatment cabotegravir-rilpivirine had similar efficacy to a ...
MARCH 8, 2019
Syphilis Risk in Women With HIV: Race, IV Drug Use and HCV
The predictors of syphilis are different in women than men.
MARCH 7, 2019
Universal Testing and Treatment Reduces New HIV Infections in Africa
The study examined the effects of a package of HIV prevention interventions on community-level HIV incidence in ...
MARCH 6, 2019
HIV Patient in Remission After HSCT Treatment
Researchers found no rebound of HIV in a patient who has been off ART for 18 months after he received a bone marrow ...
MARCH 5, 2019
